| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| W Timmerma. Dopaminergic receptor agents and the basal ganglia: pharmacological properties and interactions with the GABA-ergic system. Pharmacy world & science : PWS. vol 15. issue 2. 1993-06-11. PMID:8098242. |
dopaminergic receptor agents and the basal ganglia: pharmacological properties and interactions with the gaba-ergic system. |
1993-06-11 |
2023-08-12 |
Not clear |
| M S Aldrich, Z Hollingsworth, J B Penne. Autoradiographic studies of post-mortem human narcoleptic brain. Neurophysiologie clinique = Clinical neurophysiology. vol 23. issue 1. 1993-04-08. PMID:8383284. |
we used quantitative autoradiography to assess binding of dopaminergic, noradrenergic, and cholinergic ligands to basal ganglia and amygdala of five narcoleptic and 17 control human brains. |
1993-04-08 |
2023-08-12 |
human |
| S J Patrick, L K Snelling, L R Men. Infantile chorea following abrupt withdrawal of diazepam and pentobarbital therapy. Journal of toxicology. Clinical toxicology. vol 31. issue 1. 1993-03-17. PMID:8433409. |
we speculate that the mechanism by which chorea may occur as a withdrawal phenomenon to benzodiazepine/barbiturate treatment is by a functional overactivity of the dopaminergic system in the basal ganglia. |
1993-03-17 |
2023-08-12 |
Not clear |
| D J Cohe. [Tourette's syndrome: psychopathology of development in a model of neuropsychiatric dysfunction in children]. La Psychiatrie de l'enfant. vol 35. issue 2. 1993-03-08. PMID:1494599. |
no specific neuroanatomical or neurochemical basis has yet been discovered, but the basal ganglia and dopaminergic systems have been implicated. |
1993-03-08 |
2023-08-11 |
Not clear |
| P A Löschmann, M Kunow, H Wachte. Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's disease. Journal of neural transmission. Supplementum. vol 38. 1993-02-26. PMID:1491248. |
advance in understanding of the anatomy, physiology and pharmacology of basal ganglia organisation over the past decade revealed a functional relation between excitatory glutamatergic and the degenerated dopaminergic nigrostriatal transmitter systems which could serve as targets for pharmacological interventions in parkinson's disease. |
1993-02-26 |
2023-08-11 |
rat |
| A Nieoullon, L Kerkerian-Le Gof. Cellular interactions in the striatum involving neuronal systems using "classical" neurotransmitters: possible functional implications. Movement disorders : official journal of the Movement Disorder Society. vol 7. issue 4. 1993-02-18. PMID:1362449. |
consequently, an impairment of the dopaminergic transmission such as that occurring in parkinsonism may lead to an increase in the corticostriatal glutamatergic transmission, which may further contribute towards reinforcing the "imbalance" between subsets of striatal neuronal systems controlling the output of the basal ganglia. |
1993-02-18 |
2023-08-11 |
Not clear |
| M Weller, J Kornhube. [Pathophysiology and therapy of malignant neuroleptic syndrome]. Der Nervenarzt. vol 63. issue 11. 1993-01-22. PMID:1361662. |
an acute dopaminergic transmission block in the basal ganglia and the hypothalamus is thought to be the pathophysiological mechanism of nms. |
1993-01-22 |
2023-08-11 |
Not clear |
| H Wachtel, M Kunow, P A Löschman. NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats. Neuroscience letters. vol 142. issue 2. 1993-01-06. PMID:1280793. |
degeneration of dopaminergic nigrostriatal neurons in primate models of parkinson's disease (pd) leads to an overactivity of excitatory glutamatergic projections from the subthalamic nucleus (stn) to the output nuclei of the basal ganglia resulting in rigidity and akinesia. |
1993-01-06 |
2023-08-11 |
rat |
| C R Dermon, M Tzagournissakis, H E Savak. Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the putative excitatory neurotransmitter substance P. Neuroscience. vol 50. issue 4. 1992-12-29. PMID:1280349. |
furthermore, it is suggested that the ipsilateral basal ganglia effects induced by intranigral substance p application are mediated via both the compacta dopaminergic nigrostriatal projection and the reticulata gabaergic nigro-thalamocortico-striatal loop, whereas the contralateral basal ganglia and associated thalamocortical effects are due to the activation of the gabaergic reticulata efferents and are mediated via an interthalamic circuitry involving the motor, reticular and intralaminar thalamic nuclei. |
1992-12-29 |
2023-08-11 |
rat |
| S P Sivam, J E Kraus. Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA. Journal of neurochemistry. vol 59. issue 6. 1992-12-22. PMID:1279124. |
tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance p-encoding mrnas, and substance p receptor mrna. |
1992-12-22 |
2023-08-11 |
Not clear |
| J Hierholzer, M Cordes, L Schelosky, G Barzen, W Poewe, H Henkes, U Keske, R Horowski, R Feli. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. vol 157. issue 4. 1992-11-25. PMID:1391843. |
drug-native patients showed a significantly higher ibzm binding in the basal ganglia as compared to patients on specific dopaminergic medication. |
1992-11-25 |
2023-08-11 |
Not clear |
| A M Allen, D P MacGregor, S Y Chai, G A Donnan, S Kaczmarczyk, K Richardson, R Kalnins, J Ireton, F A Mendelsoh. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Annals of neurology. vol 32. issue 3. 1992-11-13. PMID:1416803. |
angiotensin ii receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. |
1992-11-13 |
2023-08-11 |
human |
| C R Gerfe. The neostriatal mosaic: multiple levels of compartmental organization. Journal of neural transmission. Supplementum. vol 36. 1992-10-22. PMID:1527520. |
insights into the role of dopaminergic function within the basal ganglia may have direct relevance to the development of treatments for schizophrenia. |
1992-10-22 |
2023-08-11 |
Not clear |
| L W Fitzgerald, K J Miller, A K Ratty, S D Glick, M Teitler, K W Gros. Asymmetric elevation of striatal dopamine D2 receptors in the chakragati mouse: neurobehavioral dysfunction in a transgenic insertional mutant. Brain research. vol 580. issue 1-2. 1992-09-23. PMID:1354555. |
this unique mutant provides a novel genetic model of basal ganglia dysfunction, and may be useful in studying aspects of neuropsychiatric disorders associated with dopaminergic abnormalities. |
1992-09-23 |
2023-08-11 |
mouse |
| A Reiner, R G Northcut. An immunohistochemical study of the telencephalon of the senegal bichir (Polypterus senegalus). The Journal of comparative neurology. vol 319. issue 3. 1992-07-16. PMID:1351063. |
several features of the labeling patterns obtained suggested that the dorsal and ventral subdivisions of the area ventralis are homologous as a field to the basal ganglia and septum plus other basal telencephalic regions of land vertebrates, sharks and lungfish: 1) an abundance of sp+, npy+, and enk+ fibers; 2) an abundance of th+ fibers, possibly of posterior tubercle/tegmental origin; 3) the presence of an sp+ fiber bundle that appeared to descend from basal telencephalic levels and terminate in the posterior tubercle/tegmentum, which contain th+ (possibly dopaminergic) neurons; and 4) an abundance of 5ht+ fibers, presumably of posterior tubercle/tegmental origin. |
1992-07-16 |
2023-08-11 |
Not clear |
| R L Watts, A S Mandi. The role of motor cortex in the pathophysiology of voluntary movement deficits associated with parkinsonism. Neurologic clinics. vol 10. issue 2. 1992-06-17. PMID:1584184. |
the characteristic motor deficits of parkinsonism result from dysfunction of the nigrostriatal dopaminergic system of the basal ganglia. |
1992-06-17 |
2023-08-11 |
Not clear |
| M J Steiger, M Pires, F Scaravilli, N P Quinn, C D Marsde. Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration. Movement disorders : official journal of the Movement Disorder Society. vol 7. issue 1. 1992-05-04. PMID:1557069. |
dyskinesias associated with dopaminergic treatment in idiopathic parkinson's disease (pd) can be indistinguishable from those arising spontaneously in other conditions involving degeneration of, or damage to, the basal ganglia. |
1992-05-04 |
2023-08-11 |
Not clear |
| F Mennicken, M Savasta, R Peretti-Renucci, C Feuerstei. Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935. Journal of neural transmission. General section. vol 87. issue 1. 1992-03-30. PMID:1346964. |
a dopaminergic denervation caused a complete loss of [3h]gbr 12935 in basal ganglia ipsilateral to the lesion. |
1992-03-30 |
2023-08-11 |
rat |
| B K Lipska, G E Jaskiw, F Karoum, I Phillips, J E Kleinman, D R Weinberge. Dorsal hippocampal lesion does not affect dopaminergic indices in the basal ganglia. Pharmacology, biochemistry, and behavior. vol 40. issue 1. 1992-03-10. PMID:1664108. |
dorsal hippocampal lesion does not affect dopaminergic indices in the basal ganglia. |
1992-03-10 |
2023-08-11 |
rat |
| S Holemans, F Javoy, Y Agid, E C Laterre, J M Maloteau. [3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy. Brain research. vol 565. issue 1. 1992-02-28. PMID:1837752. |
the interactions existing between glutamatergic and dopaminergic systems, notably in the basal ganglia, suggest that glutamatergic antagonists may have therapeutic interest in extrapyramidal disorders characterized by impaired dopaminergic transmission. |
1992-02-28 |
2023-08-11 |
Not clear |